• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

The Healthcare RFID Market is Expected to Continue Growing Due to New Tagging of Drugs for Anti-Counterfeiting

Posted on: Friday, 19 May 2006, 15:07 CDT

Research and Markets (http://www.researchandmarkets.com/reports/c37264) has announced the addition of RFID in Healthcare 2006-2016 to their offering.

The RFID business is growing so fast that few applicational sectors within it can grow faster. However, Healthcare RFID is doing just that - a 23 fold growth to $2.1 billion in 2016 - primarily thanks to the new tagging of drugs for anti-counterfeiting and real time location of staff, patients and assets for safety, security and cost control. Other developments include automated error reduction. For example, RFID enabled compliance monitoring blisterpacks are newly popular. Error preventing RFID is increasingly used in instruments and equipment. This unique 249 page report gives a full technical and market analysis illustrated by 70 case studies of RFID in action in hospitals, care homes and in the home. It is a vital resource for the healthcare profession and all who wish to support it.

This report has been globally researched by technical specialists and launched in 2006. Its segmented forecasts up to 2016 are based on hundreds of case studies, dozens of interviews and attending numerous conferences on four continents.

Healthcare RFID will grow from 3% to 8% of the total RFID market and its needs will be met by prosperous suppliers skilled in the necessary requirements.

70 important case studies and 24 supplier product profiles are included in the report.

Countries and regions covered include Taiwan, Japan Korea, Singapore, India, Australia, UK, Germany, Ireland, Italy, France, Israel and the USA.

The technology is fully explained - RFID in general and the eight technologies useful to Healthcare Real Time Locating Systems (RTLS). We explain what is driving item level drug tagging, RTLS, theft and error prevention, patient compliance monitoring, automatic procedure recording, secure access and the management of blood, supplies and equipment with RFID. Smart shelves, smart cabinets, talking drugs, perfection of supply chains, temperature recording RFID labels are covered. We predict what comes next.

This in-depth study contains over 245 pages, 45 detailed tables, 90 figures, and 70 case studies which provide strategic forecasts, technology, and company profiles.

Topics Covered

-- EXECUTIVE SUMMARY AND CONCLUSIONS

-- 1. INTRODUCTION

-- 1.1. Relevant challenges in healthcare

-- 1.2. Radio Frequency Identification

-- 1.3. Real Time Locating Systems

-- 1.4. Trend of frequencies

-- 1.5. Privacy issues

-- 1.6. Statement of independence

-- 2. LOCATION AND STATUS OF STAFF, VISITORS, PATIENTS AND FIXED ASSETS

-- 2.1. Challenges

-- 2.2. Primary benefits of RTLS

-- 2.3. Detailed needs, concerns, impediments for RTLS in healthcare

-- 2.4. RTLS technology

-- 2.5. Choice of technologies

-- 2.6. Suppliers

-- 2.7. RTLS Case studies: Indoor Positioning Systems for people

-- 2.8. RTLS case studies - assets and supplies

-- 3. PHARMACEUTICAL ANTICOUNTERFEITING, THEFT CONTROL AND TRACKING

-- 3.1. Challenges

-- 3.2. Attitude of legislators and the industry

-- 3.3. Technology

-- 3.4. Case studies

-- 3.5. Suppliers capabilities

-- 4. ERROR REDUCTION, RECORDING PROCEDURES, PATIENT COMPLIANCE

-- 4.1. Error reduction and recording procedures

-- 4.2. Patient compliance

-- 4.3. Case studies

-- 5. MANAGEMENT OF BLOOD, SUPPLIES, EQUIPMENT

-- 5.1. Blood testing, transport and transfusion

-- 5.2. Smart cabinets

-- 5.3. Laundry - rented textiles

-- 5.4. Document management

-- 5.5. Hearing aids

-- 5.6. Case studies

-- 5.7. Supplier capability

-- 6. OTHER USES FOR RFID IN HEALTHCARE

-- 6.1. Secure access

-- 6.2. Recording and alerting to incidents

-- 6.3. Case studies

-- 7. MARKET FORECASTS

-- 7.1. Total RFID market 2006-2016

-- 7.2. Healthcare RFID market 2006-2016

-- 7.3. RTLS market 2006-2016

Companies Mentioned

- Wal-Mart - Pfizer - GlaxoSmithKline - Abbott Laboratories - Cephalon - CVS Pharmacy USA - Felletti Spadazzi Italy - GS1 Europe - HD Smith USA - Johnson & Johnson USA - McKesson USA - Millennium Pharmaceutical UK - MIT Auto-ID Labs USA - Novartis USA - Purdue Pharma USA - Ranbaxy Pharmaceuticals India - UK Pharmaceutical UK - Unimed Pharma Korea - Walgreens USA - West Pharmaceutical Services USA - Cardinal Health USA- Bang & Olufsen Medicaid, Denmark - Precision Dynamics, USA - Brenmoor UK - Fischer Clinical Services drug trials item level, USA - Melexis, Belgium - AstraZeneca, UK - Baptist Health USA - Veterans V/A Hospitals USA - Regenesis Biomedical USA - Mediplus, UK - South Tyneside Healthcare Trust UK- Electrolux, Germany- Uchida Yoko, Japan - Yoshikawa, Japan- Hitachi, Japan - DHL

For more information visit http://www.researchandmarkets.com/reports/c37264

Source: Business Wire

More News in this Category